Evidence map›Paper›PMID 26621798›Full record

ArticleApplied microbiology and biotechnology2016

Engineering a thermostable Halothermothrix orenii β-glucosidase for improved galacto-oligosaccharide synthesis.

Noor Hassan, Barbara Geiger, Rosaria Gandini, Bharat K C Patel, Roman Kittl, Dietmar Haltrich, Thu-Ha Nguyen, Christina Divne, Tien Chye Tan

Open access · hybridAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Site-Directed Mutagenesis Increased the Catalytic Activity and Stability ofInternational journal of molecular sciences · 2025
    Article
  3. Review
  4. Design of supported organocatalysts from a biomass-derived difuran compound and catalytic assessment for lactose hydrolysis.Green chemistry : an international journal and green chemistry resource : GC · 2023
    Article
  5. Article
  6. β-galactosidase GALA fromBioengineered · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Noor HassanAlbaNova University Center, School of Biotechnology, KTH Royal Institute of Technology, Roslagstullsbacken 21, S-10691, Stockholm, Sweden.
Barbara GeigerFood Biotechnology Laboratory, BOKU-University of Natural Resources and Life Sciences Vienna, 1190, Vienna, Austria.
Rosaria GandiniAlbaNova University Center, School of Biotechnology, KTH Royal Institute of Technology, Roslagstullsbacken 21, S-10691, Stockholm, Sweden.
Bharat K C PatelMicrobial Gene Research and Resources Facility, School of Biomolecular and Physical Sciences, Griffith University, Brisbane, QLD 4111, Australia.
Roman KittlFood Biotechnology Laboratory, BOKU-University of Natural Resources and Life Sciences Vienna, 1190, Vienna, Austria.
Dietmar HaltrichFood Biotechnology Laboratory, BOKU-University of Natural Resources and Life Sciences Vienna, 1190, Vienna, Austria.
Thu-Ha NguyenFood Biotechnology Laboratory, BOKU-University of Natural Resources and Life Sciences Vienna, 1190, Vienna, Austria.
Christina DivneAlbaNova University Center, School of Biotechnology, KTH Royal Institute of Technology, Roslagstullsbacken 21, S-10691, Stockholm, Sweden.
Tien Chye TanAlbaNova University Center, School of Biotechnology, KTH Royal Institute of Technology, Roslagstullsbacken 21, S-10691, Stockholm, Sweden. tantc@kth.se.
BOKU University · ATKTH Royal Institute of Technology · SEAlbaNova · SEGriffith University · AU

Funding

Austrian Science Fund FWF P 24868Austrian Science Fund FWF P 25313Austrian Science Fund FWF W 1224
6 · The paper itself

Abstract

Lactose is produced in large amounts as a by-product from the dairy industry. This inexpensive disaccharide can be converted to more useful value-added products such as galacto-oligosaccharides (GOSs) by transgalactosylation reactions with retaining β-galactosidases (BGALs) being normally used for this purpose. Hydrolysis is always competing with the transglycosylation reaction, and hence, the yields of GOSs can be too low for industrial use. We have reported that a β-glucosidase from Halothermothrix orenii (HoBGLA) shows promising characteristics for lactose conversion and GOS synthesis. Here, we engineered HoBGLA to investigate the possibility to further improve lactose conversion and GOS production. Five variants that targeted the glycone (-1) and aglycone (+1) subsites (N222F, N294T, F417S, F417Y, and Y296F) were designed and expressed. All variants show significantly impaired catalytic activity with cellobiose and lactose as substrates. Particularly, F417S is hydrolytically crippled with cellobiose as substrate with a 1000-fold decrease in apparent k cat, but to a lesser extent affected when catalyzing hydrolysis of lactose (47-fold lower k cat). This large selective effect on cellobiose hydrolysis is manifested as a change in substrate selectivity from cellobiose to lactose. The least affected variant is F417Y, which retains the capacity to hydrolyze both cellobiose and lactose with the same relative substrate selectivity as the wild type, but with ~10-fold lower turnover numbers. Thin-layer chromatography results show that this effect is accompanied by synthesis of a particular GOS product in higher yields by Y296F and F417S compared with the other variants, whereas the variant F417Y produces a higher yield of total GOSs.

Indexed as

Protein EngineeringBacterial Proteinsbeta-GlucosidaseGalactoseHalothiobacillusKineticsLactoseOligosaccharidesSubstrate SpecificityBacterial Proteinsbeta-GlucosidaseGalactoseLactoseOligosaccharidesGalacto-oligosaccharidesHalothermophileHalothermothrixLactose conversionTransglycosylation mutantsβ-Galactosidaseβ-Glucosidase

Identifiers

PMID26621798
PMCPMC4803828
OpenAlexW2187348079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.